Showing results (171-180 of 224) with videos related to
Sort By:
Pageof 23
Gut|December 9, 2017
Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivoKatja Giersch, Oliver D Bhadra, Tassilo Volz, et al.Transboundary and Emerging Diseases|October 4, 2021
Natural co-infection of divergent hepatitis B and C virus homologues in carnivoresWendy K Jo, Jorge A Alfonso-Toledo, Monica Salas-Rojas, et al.Plos Pathogens|March 5, 2024
Comparative analysis of human, rodent and snake deltavirus replicationPierre Khalfi, Zoé Denis, Joe McKellar, et al.Nature Biotechnology|February 26, 2008
Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope proteinJoerg Petersen, Maura Dandri, Walter Mier, et al.Hepatology (Baltimore, Md.)|August 5, 2015
Present and future therapies of hepatitis B: From discovery to cureT Jake Liang, Timothy M Block, Brian J McMahon, et al.Journal of Hepatology|February 10, 2024
Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsiesLena Allweiss, Annika Volmari, Vithika Suri, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 2, 2025
Pharmacological Inhibition of c-Jun N-Terminal Kinase Activity Exacerbates Liver Damage in Schistosoma mansoni Infected MiceFrederik Stettler, Lukas Knedla, Maximilian Hagen, et al.Proceedings of the National Academy of Sciences of the United States of America|July 12, 2020
Mammalian deltavirus without hepadnavirus coinfection in the neotropical rodent Proechimys semispinosusSofia Paraskevopoulou, Fabian Pirzer, Nora Goldmann, et al.Plos One|September 13, 2011
The novel immunosuppressive protein kinase C inhibitor sotrastaurin has no pro-viral effects on the replication cycle of hepatitis B or C virusThomas von Hahn, Andreas Schulze, Ivan Chicano Wust, et al.Gut|January 27, 2023
Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cureLena Allweiss, Barbara Testoni, Mei Yu, et al.Pageof 23